Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
Date:7/30/2009

PITTSBURGH, July 30 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and six months ended June 30, 2009.

Financial Highlights

  • Adjusted diluted EPS, which excludes the impact of certain purchase accounting items as well as other non-cash and/or non-recurring items as detailed below, was $0.32 and $0.65 for the three and six months ended June 30, 2009, compared to $0.20 and $0.29 for the same prior year periods;
  • Total revenues of $1.27 billion for the three months ended June 30, 2009, an increase of $63.9 million over the same prior year period;
  • Total revenues of $2.48 billion for the six months ended June 30, 2009, an increase of $199.3 million over the same prior year period;
  • On a GAAP basis, the company reported diluted EPS of $0.19 and $0.42 for the three and six months ended June 30, 2009, compared to a loss per share of $0.05 and $1.52 in the same prior year periods. The six months ended June 30, 2008 included a non-cash goodwill impairment charge of $385.0 million related to the Specialty Segment.

Mylan's Chairman and CEO Robert J. Coury commented: "This was yet another successful quarter on many fronts for Mylan as, across the board, we delivered another quarter of financial performance that exceeded our expectations. Our powerful and integrated global platform enabled each of our businesses to generate year-over-year quarterly revenue growth on a constant currency basis and to deliver additional operational efficiencies as well. In addition, we took an important initial step in one of our targeted areas of future growth by entering into a collaborative agreement with Biocon in the area of generic biologics."


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
2. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
3. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
4. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
5. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
6. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
7. Mylan Confirms Four First-to-File Challenges
8. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
9. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
10. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... polarity of a magnet using an electric field ... principle of the next-generation technology for information processing ... the MEM effect, due to the coexistence of ... the coexistence of spontaneous electric and magnetic polarizations ... application potential of the MEM effect. This article ...
(Date:9/12/2014)... 2014 Research and Markets has ... Photoresist Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... industry . The report provides a basic ... industry chain structure. The dry film photoresist market analysis ...
(Date:9/12/2014)... Sandia Biotech, Inc. announced today that ... STC.UNM (STC) for a technology developed by researchers at ... Mexico, and Queen Mary University of London in London, ... Fluorescent Antibody Technology Platform (RFAP) was developed by Dr. ... Dr. Angray Kang from Queen Mary’s Department of Molecular ...
(Date:9/11/2014)... A team of Berkeley Lab researchers believes it ... properties of single atomic layers of transition metal ... great promise for nanoelectronic and photonic applications. ... monolayers of tungsten disulfide, one of the most ... the existence of excitonic dark states energy ...
Breaking Biology Technology:Global Dry Film Photoresist Industry Report 2014 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4Excitonic dark states shed light on TMDC atomic layers 2Excitonic dark states shed light on TMDC atomic layers 3
... new white papers detailing sterility testing essentials are ... www.microtestlabs.com ). The white papers, one which ... which is specialized for pharmaceutical manufacturers, presents the ... and reviews different testing methodologies.For medical device manufacturers, ...
... French agency Agence de Medecine,Preventive (AMP) announced today ... for the SIVAC (Supporting Independent Immunization and,Vaccine Advisory ... development of national immunization technical advisory groups in ... Asia. These committees will help,national health authorities to ...
... PLYMOUTH MEETING, Pa., Jan. 12 /PRNewswire-Asia-FirstCall/ -- BMP ... or the "Company"), today announced,that senior executives voluntarily ... and 2009. Senior executives rescinded any 2008 ... while also reducing,stock option compensation for 2009. ...
Cached Biology Technology:Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees) 2French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees) 3BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009 2
(Date:9/15/2014)... Department of Science and Technology in Society in the ... Tech, has won a 2014 National Science Foundation Faculty ... problems of creating a global nuclear emergency response plan. ... Power Plant in March 2011 was a turning point ... said. Three of the plant,s six nuclear reactors melted ...
(Date:9/15/2014)... -- Speed and agility are hallmarks of the cheetah: The ... to accelerate to 60 mph in just a few seconds. ... its legs in tandem, bounding until it reaches a full ... bounding that they,ve successfully implemented in a robotic cheetah ... that weighs about as much as its feline counterpart. The ...
(Date:9/15/2014)... is no published account where hippopotamuses are demonstrably shown ... of water. But if they can,t swim, how did ... widely accepted models for the methods, patterns, and timing ... Cyprus, Crete, and Madagascar) may need to be reconsidered. ... the mainland are not currently supported by positive ...
Breaking Biology News(10 mins):'Nuclear disasters don't respect national boundaries' 2Run, cheetah, run 2Run, cheetah, run 3
... the National Institutes of Health will explore the role ... by NIH,s National Institute of Environmental Health Sciences (NIEHS), ... people more vulnerable to heat exposure; changing weather patterns; ... toxic chemicals; and the negative effects of climate change ...
... discovered in the 16-23 million years old sediments of the ... Helophorus sibiricus , a member of the water scavenger ... in Eurasia and reaches even North America. The species was ... based on specimens collected at Lake Baikal. It is aquatic ...
... 2011. In the central Arctic the proportion of old, thick ... largely consists of thin, one-year-old floes. This is one of ... Polar and Marine Research in the Helmholtz Association brought back ... The ship arrived at its home port of Bremerhaven ...
Cached Biology News:NIH launches research program to explore health effects from climate change 2NIH launches research program to explore health effects from climate change 3A living species of aquatic beetle found in 20-million-year-old sediments 2Young and thin instead of old and bulky 2Young and thin instead of old and bulky 3Young and thin instead of old and bulky 4
... Uncover the biological data hidden in your ... flexible manufacturing allows you to create your own ... Design at your own pace and receive delivery ... world. eArray is a secure, online array creation ...
... Microsomal vesicles are used to study ... proteins. Processing events such as signal ... core glycosylation can be examined by ... in vitro in the presence of ...
Procollagen type I C-terminal propeptide (human, PICP)...
... in Early Drug Development with Imaging Mass ... drug compound localization data in early drug ... mass spectrometry service maps unlabeled ... so you can localize drugs and metabolites ...
Biology Products: